Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ireland-based Perrigo Company has launched, through a distribution and supply agreement, methazolamide tablets, the generic equivalent to Neptazane tablets.
Subscribe to our email newsletter
The product is a component of the contingent rights the company received in connection with its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals and its affiliates in June 2013.
The tablets will be used to treat ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.
Perrigo chairman, president and CEO Joseph Papa said, "This launch reflects our continuing investment in new products, is a great addition to the portfolio of ophthalmic products Perrigo is marketing today and is just another example of our commitment to driving additional value for our shareholders."
The company is focused in the development, manufacturing and distributing of OTC and generic prescription pharmaceuticals, nutritional products and active pharmaceutical ingredients (API), and receives royalties from Multiple Sclerosis drug Tysabri.